IPD NMA results: EQ-5D preference scores endpointa | Model 1, ANCOVA, change in EQ-5D scores, adjusted for baseline | Model 3, change in EQ-5D scores, without baseline adjustment | Model 4, follow-up EQ-5D score, without baseline adjustment | ||
---|---|---|---|---|---|
Median MCMC posterior sample (95Â % CrI) | Median MCMC posterior sample (95Â % CrI) | Median MCMC posterior sample (95Â % CrI) | |||
Relative treatment effects | Osteoarthritis of the knee | SHAM vs UC | 0.057 (0.013, 0.095) | 0.077 (0.033, 0.118) | 0.051 (0.008, 0.094) |
ACU vs UC | 0.079 (0.042, 0.114) | 0.093 (0.054, 0.129) | 0.074 (0.035, 0.113) | ||
ACU vs SHAM | 0.022 (-0.014, 0.060) | 0.016 (-0.022, 0.054) | 0.023 (-0.014, 0.065) | ||
Headache | SHAM vs UC | 0.052 (0.010, 0.095) | 0.044 (0.002, 0.086) | 0.052 (0.007, 0.098) | |
ACU vs UC | 0.056 (0.021, 0.092) | 0.057 (0.023, 0.090) | 0.054 (0.016, 0.092) | ||
ACU vs SHAM | 0.004 (-0.035, 0.042) | 0.013 (-0.025, 0.051) | 0.002 (-0.038, 0.040) | ||
Musculoskeletal | SHAM vs UC | 0.059 (0.017, 0.101) | 0.062 (0.019, 0.104) | 0.054 (0.010, 0.099) | |
ACU vs UC | 0.082 (0.047, 0.116) | 0.084 (0.048, 0.119) | 0.080 (0.044, 0.118) | ||
ACU vs SHAM | 0.023 (-0.008, 0.053) | 0.022 (-0.011, 0.055) | 0.026 (-0.006, 0.056) | ||
 | Between-study variance | 0.001 (0, 0.003) | 0.001 (0, 0.003) | 0.001 (0, 0.003) | |
Total residual deviance b | 15,850 (15,480; 16,230) | 16,990 (16,570; 17,420) | 15,370 (15,010; 15,730) | ||
Deviance information criterion c | -6,420.4 | -69.9 | -3,823.7 |